FDA approves Teva's generic Adderall XR capsules

02/15/2013 | Bloomberg Businessweek

The FDA has granted Teva Pharmaceutical Industries approval for its generic form of Shire's attention-deficit/hyperactivity disorder drug Adderall XR in six strengths. Teva has sold an authorized generic since 2009 and is not launching its own yet. The agreement between Teva and Shire ends next year.

View Full Article in:

Bloomberg Businessweek

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC